Cargando…
Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes
BACKGROUND: Myelodysplastic syndromes (MDS) is a group of heterogeneous myeloid clonal diseases originating from hematopoietic stem cells. It has been demonstrated that apolipoproteins A1(ApoA1) are associated with disease risk in many cancer types. However, there still lacks evidence regarding the...
Autores principales: | Shi, Cong, Gong, Shengping, Wu, An, Yang, Shujun, Zou, Duobing, Zhang, Yi, Wu, Ningning, Ma, Chao, Shi, Songqiu, Chen, Ying, Wu, Ying, Zheng, Xiaojiao, Huang, Zhenya, Ding, Jianghua, Ouyang, Guifang, Mu, Qitian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805344/ https://www.ncbi.nlm.nih.gov/pubmed/35100989 http://dx.doi.org/10.1186/s12885-022-09248-2 |
Ejemplares similares
-
Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome
por: Shi, Cong, et al.
Publicado: (2022) -
Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome
por: Chen, Ying, et al.
Publicado: (2023) -
MLL-SEPT5 Fusion Transcript in Myelodysplastic Syndrome Patient With t(11;22)(q23;q11)
por: Zou, Duobing, et al.
Publicado: (2021) -
The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes
por: Shi, Cong, et al.
Publicado: (2022) -
Prognostic significance of U2AF1 mutations in
myelodysplastic syndromes: a meta-analysis
por: Li, Bixia, et al.
Publicado: (2019)